Dr Azita Simoni, MD - Medicare Dermatology in Thousand Oaks, CA

Dr Azita Simoni, MD is a medicare enrolled "Dermatology" physician in Thousand Oaks, California. She went to State University Of New York Downstate Medical Center and graduated in 2000 and has 24 years of diverse experience with area of expertise as Dermatology. She is a member of the group practice Csi Medical Group and her current practice location is 425 Haaland Dr Ste 204, Thousand Oaks, California. You can reach out to her office (for appointments etc.) via phone at (805) 497-8080.

Dr Azita Simoni is licensed to practice in California (license number A101945) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1366418931.

Contact Information

Dr Azita Simoni, MD
425 Haaland Dr Ste 204,
Thousand Oaks, CA 91361-5231
(805) 497-8080
(805) 497-8806



Physician's Profile

Full NameDr Azita Simoni
GenderFemale
SpecialityDermatology
Experience24 Years
Location425 Haaland Dr Ste 204, Thousand Oaks, California
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Azita Simoni attended and graduated from State University Of New York Downstate Medical Center in 2000
  NPI Data:
  • NPI Number: 1366418931
  • Provider Enumeration Date: 02/24/2006
  • Last Update Date: 04/05/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 0547229254
  • Enrollment ID: I20110218000966

Medical Identifiers

Medical identifiers for Dr Azita Simoni such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1366418931NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207N00000XDermatology A101945 (California)Primary
207N00000XDermatology 224015 (New York)Secondary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Csi Medical Group5890916845103

News Archive

Diabetes drug reduces cardiovascular events and kidney problems, study finds

A clinical trial that followed more than 9,900 people in 24 countries has found that the drug dulaglutide reduced cardiovascular events and kidney problems in middle-aged and older people with Type 2 diabetes.

InSightec: First patient treated in ExAblate Neuro Phase III pivotal trial for tremor

InSightec Ltd, the global leader in MR guided focused ultrasound, announced that the first patient has been treated as part of an ExAblate Neuro Phase III pivotal trial. The trial is a multicenter, double-blinded, randomized study to evaluate the efficacy and safety of treatment using the ExAblate Neuro in medication-refractory essential tremor patients.

Study reports 'unmet need' for joint replacement surgery after Medicaid expansion

States that have expanded Medicaid eligibility under the Affordable Care Act have seen an "early surge in demand" for hip and knee replacement surgery, reports a study in the September 2, 2020 issue of The Journal of Bone & Joint Surgery.

Shionogi-ViiV Healthcare to advance '572 inhibitor into Phase III clinical trials

Shionogi-ViiV Healthcare LLC today announced that it will be progressing its once-daily, unboosted investigational integrase inhibitor, S/GSK1349572 ('572) into Phase III clinical trials. '572 will be the only once-daily, unboosted integrase inhibitor in Phase III clinical development.

Seminar highlights latest treatment options for common medical conditions that affect men

Dr. Y. Mark Hong, with Affiliated Urologists, a specialist in men's health issues, will be leading a free Men's Health Seminar on Thursday, January 21st. The program, to be held at 5:00 pm at the Moon Valley Country Club, will explain the latest treatment options for one of the most common conditions affecting men today: Benign Prostate Hyperplasia (also known as Enlarged Prostate). A question and answer period will follow the program.

Read more Medical News

› Verified 8 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Azita Simoni allows following entities to bill medicare on her behalf.
Entity NameSkin And Beauty Center Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1073751129
PECOS PAC ID: 8628170347
Enrollment ID: O20070227000738

News Archive

Diabetes drug reduces cardiovascular events and kidney problems, study finds

A clinical trial that followed more than 9,900 people in 24 countries has found that the drug dulaglutide reduced cardiovascular events and kidney problems in middle-aged and older people with Type 2 diabetes.

InSightec: First patient treated in ExAblate Neuro Phase III pivotal trial for tremor

InSightec Ltd, the global leader in MR guided focused ultrasound, announced that the first patient has been treated as part of an ExAblate Neuro Phase III pivotal trial. The trial is a multicenter, double-blinded, randomized study to evaluate the efficacy and safety of treatment using the ExAblate Neuro in medication-refractory essential tremor patients.

Study reports 'unmet need' for joint replacement surgery after Medicaid expansion

States that have expanded Medicaid eligibility under the Affordable Care Act have seen an "early surge in demand" for hip and knee replacement surgery, reports a study in the September 2, 2020 issue of The Journal of Bone & Joint Surgery.

Shionogi-ViiV Healthcare to advance '572 inhibitor into Phase III clinical trials

Shionogi-ViiV Healthcare LLC today announced that it will be progressing its once-daily, unboosted investigational integrase inhibitor, S/GSK1349572 ('572) into Phase III clinical trials. '572 will be the only once-daily, unboosted integrase inhibitor in Phase III clinical development.

Seminar highlights latest treatment options for common medical conditions that affect men

Dr. Y. Mark Hong, with Affiliated Urologists, a specialist in men's health issues, will be leading a free Men's Health Seminar on Thursday, January 21st. The program, to be held at 5:00 pm at the Moon Valley Country Club, will explain the latest treatment options for one of the most common conditions affecting men today: Benign Prostate Hyperplasia (also known as Enlarged Prostate). A question and answer period will follow the program.

Read more Medical News

› Verified 8 days ago

Entity NameCsi Medical Group
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1871909804
PECOS PAC ID: 5890916845
Enrollment ID: O20141016001930

News Archive

Diabetes drug reduces cardiovascular events and kidney problems, study finds

A clinical trial that followed more than 9,900 people in 24 countries has found that the drug dulaglutide reduced cardiovascular events and kidney problems in middle-aged and older people with Type 2 diabetes.

InSightec: First patient treated in ExAblate Neuro Phase III pivotal trial for tremor

InSightec Ltd, the global leader in MR guided focused ultrasound, announced that the first patient has been treated as part of an ExAblate Neuro Phase III pivotal trial. The trial is a multicenter, double-blinded, randomized study to evaluate the efficacy and safety of treatment using the ExAblate Neuro in medication-refractory essential tremor patients.

Study reports 'unmet need' for joint replacement surgery after Medicaid expansion

States that have expanded Medicaid eligibility under the Affordable Care Act have seen an "early surge in demand" for hip and knee replacement surgery, reports a study in the September 2, 2020 issue of The Journal of Bone & Joint Surgery.

Shionogi-ViiV Healthcare to advance '572 inhibitor into Phase III clinical trials

Shionogi-ViiV Healthcare LLC today announced that it will be progressing its once-daily, unboosted investigational integrase inhibitor, S/GSK1349572 ('572) into Phase III clinical trials. '572 will be the only once-daily, unboosted integrase inhibitor in Phase III clinical development.

Seminar highlights latest treatment options for common medical conditions that affect men

Dr. Y. Mark Hong, with Affiliated Urologists, a specialist in men's health issues, will be leading a free Men's Health Seminar on Thursday, January 21st. The program, to be held at 5:00 pm at the Moon Valley Country Club, will explain the latest treatment options for one of the most common conditions affecting men today: Benign Prostate Hyperplasia (also known as Enlarged Prostate). A question and answer period will follow the program.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Azita Simoni is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Azita Simoni, MD
50 N La Cienega Blvd, Suite 150,
Beverly Hills, CA 90211-2227

Ph: (310) 889-4882
Dr Azita Simoni, MD
425 Haaland Dr Ste 204,
Thousand Oaks, CA 91361-5231

Ph: (805) 497-8080

News Archive

Diabetes drug reduces cardiovascular events and kidney problems, study finds

A clinical trial that followed more than 9,900 people in 24 countries has found that the drug dulaglutide reduced cardiovascular events and kidney problems in middle-aged and older people with Type 2 diabetes.

InSightec: First patient treated in ExAblate Neuro Phase III pivotal trial for tremor

InSightec Ltd, the global leader in MR guided focused ultrasound, announced that the first patient has been treated as part of an ExAblate Neuro Phase III pivotal trial. The trial is a multicenter, double-blinded, randomized study to evaluate the efficacy and safety of treatment using the ExAblate Neuro in medication-refractory essential tremor patients.

Study reports 'unmet need' for joint replacement surgery after Medicaid expansion

States that have expanded Medicaid eligibility under the Affordable Care Act have seen an "early surge in demand" for hip and knee replacement surgery, reports a study in the September 2, 2020 issue of The Journal of Bone & Joint Surgery.

Shionogi-ViiV Healthcare to advance '572 inhibitor into Phase III clinical trials

Shionogi-ViiV Healthcare LLC today announced that it will be progressing its once-daily, unboosted investigational integrase inhibitor, S/GSK1349572 ('572) into Phase III clinical trials. '572 will be the only once-daily, unboosted integrase inhibitor in Phase III clinical development.

Seminar highlights latest treatment options for common medical conditions that affect men

Dr. Y. Mark Hong, with Affiliated Urologists, a specialist in men's health issues, will be leading a free Men's Health Seminar on Thursday, January 21st. The program, to be held at 5:00 pm at the Moon Valley Country Club, will explain the latest treatment options for one of the most common conditions affecting men today: Benign Prostate Hyperplasia (also known as Enlarged Prostate). A question and answer period will follow the program.

Read more News

› Verified 8 days ago


Dermatology Doctors in Thousand Oaks, CA

Dr. Seth R Stevens, M.D.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 267 W Hillcrest Dr, Thousand Oaks, CA 91360
Phone: 805-497-1694    Fax: 805-373-7493
Dr. Navid Ezra, M.D.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 3095 Old Conejo Rd, Suite 200, Thousand Oaks, CA 91320
Phone: 805-222-5803    
Sean Condon, MD
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 267 W Hillcrest Dr, Thousand Oaks, CA 91360
Phone: 805-497-1694    
Dr. Jeanette Kamell Mitchell, MD
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 55 Rolling Oaks Dr Ste 200, Thousand Oaks, CA 91361
Phone: 805-497-7529    Fax: 805-494-3486
Robert A Gold, MD
Dermatology
Medicare: Medicare Enrolled
Practice Location: 45 North Erbes Road, Thousand Oaks, CA 91362
Phone: 818-404-3200    
Dr. Nima Milani-nejad, M.D.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 100 Moody Ct Ste 200, Thousand Oaks, CA 91360
Phone: 805-418-3500    Fax: 805-418-3505

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.